Amprion To Expand Diagnostic Testing For Neurodegenerative Disorders With Investment From Decathlon Capital Partners
Agreement provides flexible amortization without dilution or loss of management control SAN DIEGO, July 8, 2026 /PRNewswire/ -- Amprion, Inc., a global leader advancing diagnosis of neurodegenerative disorders through seed-amplification testing, has reached an agreement with Decathlon...
Agreement provides flexible amortization without dilution or loss of management control SAN DIEGO, July 8, 2026 /PRNewswire/ -- Amprion, Inc., a global leader advancing diagnosis of neurodegenerative disorders through seed-amplification testing, has reached an agreement with Decathlon...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.